Compare CVEO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVEO | TKNO |
|---|---|---|
| Founded | 1977 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.5M | 308.3M |
| IPO Year | 2013 | 2021 |
| Metric | CVEO | TKNO |
|---|---|---|
| Price | $30.30 | $5.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | 135.5K | ★ 224.2K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $7.72 | $8.27 |
| Revenue Next Year | $5.61 | $13.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $19.75 | $1.91 |
| 52 Week High | $36.50 | $6.68 |
| Indicator | CVEO | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 34.09 | 67.05 |
| Support Level | $29.88 | $3.33 |
| Resistance Level | $35.91 | $5.84 |
| Average True Range (ATR) | 1.47 | 0.42 |
| MACD | -0.26 | 0.06 |
| Stochastic Oscillator | 14.74 | 85.14 |
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.